Summary

Endocrine Function Diagnostics Market Summary

The global endocrine function diagnostics market size was estimated at USD 13.16 billion in 2024 and is projected to reach USD 26.23 billion by 2033, growing at a CAGR of 8.0% from 2025 to 2033. The growing prevalence of endocrine disorders, strong shift towards precision diagnostics, and technological innovations in assays and platforms are some of the major factors contributing to market growth.

According to statistics published by the American Cancer Society, 44,020 new cases of thyroid cancer were reported in the U.S. in 2025. The rate of new thyroid cancers was growing faster compared to other cancers in the U.S. This leads to consistent growth in demand for routine endocrine panel testing in hospitals, clinics, and diagnostic laboratories.

Advancements in product technologies fuel the market demand. According to the Cureus, part of the Springer Nature group, published an article in October 2023, in recent years, remarkable progress has been made in the treatment of endocrine system diseases and arrhythmia. Endocrine system disorders include a variety of diseases such as diabetes, thyroid dysfunction, and adrenal gland disease. Advances in biomarker identification and genomic profiling have made it possible to make more accurate diagnoses and develop individualized treatment plans. In addition, modern drugs and advanced delivery systems represent great progress in achieving improved glycemic control and minimizing the adverse effects of endocrine disorders in individuals characterized by improper heart rhythms. Arrhythmia poses a significant risk to cardiovascular health. Strategies to treat arrhythmia include wearable cardiac monitors, catheter-based ablation techniques, and artificial intelligence-based predictive algorithms. These advances facilitate early detection, risk stratification, and execution of targeted interventions, ultimately leading to improved patient outcomes.

The demand for endocrine function diagnostics is increasing as adults become more health-conscious and the number of lifestyle-related diseases increases. This increased awareness is contributing to the rise of home health care and point-of-care (POC) devices that deliver faster and more efficient results. Home care and POC devices are easy to use and provide a cost-effective alternative for adults and the growing elderly population. The WHO estimates that by 2025, about 167 million people, including adults and children, will be in poor health due to being overweight or obese. The prediction of these diseases is likely to impact the market and result in significant growth during the forecast period.

Increasing health complications in the elderly population are expected to drive the market growth during the forecast period. According to the National Council on Aging article in August 2023, 94.9% of adults aged 60 and older have at least one disease, and 78.7% have two or more. Obesity, which affects about 42% of adults over age 60, can also increase the risk of diseases such as heart disease, type 2 diabetes, and cancer. With the increase in the affected population, the number of tests used in endocrinology has increased substantially. These aspects are expected to boost market growth.

Global Endocrine Function Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global endocrine function diagnostics market report based on test type, technology, end use, application and region:

• Test Type Outlook (Revenue in USD Million, 2021 - 2033)
• Estradiol (E2) Test
• Follicle Stimulating Hormone (FSH) Test
• Human Chorionic Gonadotropin (hCG) Hormone Test
• Luteinizing Hormone (LH) Test
• Dehydroepiandrosterone Sulfate (DHEAS) Test
• Progesterone Test
• Testosterone Test
• Thyroid Stimulating Hormone (TSH) Test
• Prolactin Test
• Cortisol Test
• Insulin Test
• Others
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Tandem Mass Spectrometry
• Immunoassay
• Monoclonal & Polyclonal Antibody Technologies
• Sensor Technology
• Clinical Chemistry
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Thyroid Disorders
• Diabetes & Metabolic Disorders
• Adrenal Disorders
• Pituitary Disorders
• Reproductive & Fertility Disorders
• Bone-Mineral Disorders
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Commercial Laboratories
• Ambulatory Care Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Technology
1.2.3. End-use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test Type
2.2.2. Technology
2.2.3. End-use
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Endocrine Function Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of endocrine disorders
3.2.1.2. Rising demand for home health care and awareness of routine testing
3.2.1.3. Advancements in product technologies
3.2.1.4. Increasing investments in research activities for disease understanding
3.2.2. Market restraint analysis
3.2.2.1. High Cost of Advanced Endocrine Function Diagnostics Devices
3.2.2.2. Lack of Awareness in Underdeveloped and Developing Countries
3.3. Endocrine Function Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pricing Analysis
Chapter 4. Endocrine Function Diagnostics Market: Test Type Estimates & Trends Analysis
4.1. Test Type Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Endocrine Function Diagnostics Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
4.4.1. Estradiol (E2) Test
4.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.2. Follicle Stimulating Hormone (FSH) Test
4.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.3. Human Chorionic Gonadotropin (hCG) Hormone Test
4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.4. Luteinizing Hormone (LH) Test
4.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.5. Dehydroepiandrosterone Sulfate (DHEAS) Test
4.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.6. Progesterone Test
4.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.7. Testosterone Test
4.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.8. Thyroid Stimulating Hormone (TSH) Test
4.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.9. Prolactin Test
4.4.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.10. Cortisol Test
4.4.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.11. Insulin Test
4.4.11.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
4.4.12. Others
4.4.12.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Endocrine Function Diagnostics Market: Technology Estimates & Trends Analysis
5.1. Technology Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Endocrine Function Diagnostics Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
5.4.1. Tandem Mass Spectrometry
5.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.4.2. Immunoassay
5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.4.3. Monoclonal & Polyclonal Antibody Technologies
5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.4.4. Sensor Technology
5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.4.5. Clinical Chemistry
5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
5.4.6. Others
5.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Endocrine Function Diagnostics Market: Application Estimates & Trends Analysis
6.1. Application Market Share, 2024 & 2033
6.2. Segment Dashboard
6.3. Global Endocrine Function Diagnostics Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
6.4.1. Thyroid Disorders
6.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.2. Diabetes & Metabolic Disorders
6.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.3. Adrenal Disorders
6.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.4. Pituitary Disorders
6.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.5. Reproductive & Fertility Disorders
6.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.6. Bone-Mineral Disorders
6.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
6.4.7. Others
6.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Endocrine Function Diagnostics Market: End Use Estimates & Trends Analysis
7.1. End Use Market Share, 2024 & 2033
7.2. Segment Dashboard
7.3. Global Endocrine Function Diagnostics Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
7.4.1. Hospitals
7.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.2. Commercial Laboratories
7.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.3. Ambulatory Care Centers
7.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
7.4.4. Others
7.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Endocrine Function Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Competitive scenario
8.5.1.3. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Competitive scenario
8.6.1.3. UK market estimates and forecasts, 2021 - 2033 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. France market estimates and forecasts, 2021 - 2033 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Competitive scenario
8.6.4.3. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Competitive scenario
8.6.5.3. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Competitive scenario
8.6.6.3. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Competitive scenario
8.6.7.3. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Competitive scenario
8.6.8.3. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Competitive scenario
8.7.1.3. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. China market estimates and forecasts, 2021 - 2033 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. India market estimates and forecasts, 2021 - 2033 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Competitive scenario
8.7.4.3. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Competitive scenario
8.7.5.3. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Competitive scenario
8.7.6.3. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Competitive scenario
8.8.1.3. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Competitive scenario
8.8.2.3. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Competitive scenario
8.9.1.3. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Competitive scenario
8.9.2.3. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Competitive scenario
8.9.3.3. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Competitive scenario
8.9.4.3. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Company Profiles
9.3.1. Abbott Laboratories
9.3.1.1. Company overview
9.3.1.2. Financial performance
9.3.1.3. Test Type benchmarking
9.3.1.4. Strategic initiatives
9.3.2. AB Sciex
9.3.2.1. Company overview
9.3.2.2. Financial performance
9.3.2.3. Test Type benchmarking
9.3.2.4. Strategic initiatives
9.3.3. Agilent Technologies Inc.
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Test Type benchmarking
9.3.3.4. Strategic initiatives
9.3.4. bioMerieux SA
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Test Type benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Bio-Rad Laboratories Inc.
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Test Type benchmarking
9.3.5.4. Strategic initiatives
9.3.6. DiaSorin S.p.A.
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Test Type benchmarking
9.3.6.4. Strategic initiatives
9.3.7. F. Hoffmann-La Roche Ltd.
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Test Type benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Laboratory Corporation of America Holdings
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Test Type benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Quest Diagnostics Incorporated
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Test Type benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Ortho Clinical Diagnostics
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Test Type benchmarking
9.3.10.4. Strategic initiatives

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1 List of abbreviation
Table 2 North America Endocrine function diagnostics market, by region, 2021 - 2033 (USD Million)
Table 3 North America Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 4 North America Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 5 North America Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 6 North America Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 7 U.S. Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 8 U.S. Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 9 U.S. Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 10 U.S. Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 11 Canada Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 12 Canada Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 13 Canada Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 14 Canada Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 15 Mexico Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 16 Mexico Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 17 Mexico Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 18 Mexico Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 19 Europe Endocrine function diagnostics market, by region, 2021 - 2033 (USD Million)
Table 20 Europe Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 21 Europe Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 22 Europe Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 23 Europe Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 24 Germany Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 25 Germany Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 26 Germany Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 27 Germany Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 28 UK Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 29 UK Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 30 UK Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 31 UK Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 32 France Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 33 France Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 34 France Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 35 France Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 36 Italy Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 37 Italy Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 38 Italy Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 39 Italy Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 40 Spain Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 41 Spain Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 42 Spain Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 43 Spain Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 44 Denmark Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 45 Denmark Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 46 Denmark Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 47 Denmark Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 48 Sweden Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 49 Sweden Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 50 Sweden Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 51 Sweden Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 52 Norway Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 53 Norway Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 54 Norway Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 55 Norway Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 56 Asia Pacific Endocrine function diagnostics market, by region, 2021 - 2033 (USD Million)
Table 57 Asia Pacific Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 58 Asia Pacific Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 59 Asia Pacific Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 60 Asia Pacific Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 61 China Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 62 China Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 63 China Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 64 China Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 65 Japan Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 66 Japan Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 67 Japan Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 68 Japan Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 69 India Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 70 India Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 71 India Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 72 India Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 73 South Korea Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 74 South Korea Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 75 South Korea Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 76 South Korea Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 77 Australia Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 78 Australia Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 79 Australia Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 80 Australia Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 81 Thailand Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 82 Thailand Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 83 Thailand Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 84 Thailand Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 85 Latin America Endocrine function diagnostics market, by region, 2021 - 2033 (USD Million)
Table 86 Latin America Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 87 Latin America Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 88 Latin America Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 89 Latin America Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 90 Brazil Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 91 Brazil Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 92 Brazil Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 93 Brazil Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 94 Argentina Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 95 Argentina Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 96 Argentina Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 97 Argentina Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 98 MEA Endocrine function diagnostics market, by region, 2021 - 2033 (USD Million)
Table 99 MEA Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 100 MEA Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 101 MEA Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 102 MEA Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 103 South Africa Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 104 South Africa Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 105 South Africa Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 106 South Africa Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 107 Saudi Arabia Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 108 Saudi Arabia Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 109 Saudi Arabia Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 110 Saudi Arabia Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 111 UAE Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 112 UAE Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 113 UAE Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 114 UAE Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)
Table 115 Kuwait Endocrine function diagnostics market, by test type, 2021 - 2033 (USD Million)
Table 116 Kuwait Endocrine function diagnostics market, by technology, 2021 - 2033 (USD Million)
Table 117 Kuwait Endocrine function diagnostics market, by application, 2021 - 2033 (USD Million)
Table 118 Kuwait Endocrine function diagnostics market, by end use, 2021 - 2033 (USD Million)List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Endocrine function diagnostics market: market outlook
Fig. 14 Endocrine function diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Endocrine function diagnostics market driver impact
Fig. 20 Endocrine function diagnostics market restraint impact
Fig. 21 Endocrine function diagnostics market strategic initiatives analysis
Fig. 22 Endocrine function diagnostics market: Test Type movement analysis
Fig. 23 Endocrine function diagnostics market: Test Type outlook and key takeaways
Fig. 24 Estradiol (E2) Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 25 Follicle Stimulating Hormone (FSH) Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 26 Human Chorionic Gonadotropin (hCG) Hormone Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 27 Luteinizing Hormone (LH) Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 28 Dehydroepiandrosterone Sulfate (DHEAS) Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 29 Progesterone Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 30 Testosterone Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 31 Thyroid Stimulating Hormone (TSH) Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 32 Prolactin Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 33 Cortisol Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 34 Insulin Test market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 35 Others market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 36 Endocrine function diagnostics Market: Technology movement Analysis
Fig. 37 Endocrine function diagnostics market: Technology outlook and key takeaways
Fig. 38 Tandem Mass Spectrometry market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Immunoassay market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Monoclonal & Polyclonal Antibody Technologies market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Sensor Technology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Clinical Chemistry market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Endocrine function diagnostics Market: Application movement analysis
Fig. 45 Endocrine function diagnostics market: Application outlook and key takeaways
Fig. 46 Thyroid Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Diabetes & Metabolic Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Adrenal Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Pituitary Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 Reproductive & Fertility Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Bone-Mineral Disorders market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 Endocrine function diagnostics market: End Use movement analysis
Fig. 54 Endocrine function diagnostics market: End Use outlook and key takeaways
Fig. 55 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Commercial Laboratories market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Ambulatory Care Centers market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Global Endocrine function diagnostics market: Regional movement analysis
Fig. 60 Global Endocrine function diagnostics market: Regional outlook and key takeaways
Fig. 61 Global Endocrine function diagnostics market share and leading players
Fig. 62 North America market share and leading players
Fig. 63 Europe market share and leading players
Fig. 64 Asia Pacific market share and leading players
Fig. 65 Latin America market share and leading players
Fig. 66 Middle East & Africa market share and leading players
Fig. 67 North America, by country
Fig. 68 North America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 69 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 70 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 71 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 72 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 73 UK market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 74 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 75 France market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 76 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 77 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 78 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 79 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 80 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 81 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 82 China market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 83 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 84 India market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 85 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 86 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 87 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 88 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 89 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 90 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 91 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 92 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 93 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 94 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 95 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 96 Market share of key market players- Endocrine function diagnostics market